SCYX Q4 2017 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$7M-11189.1% margin

Net Income

-$8M-11859.4% margin

EPS (Diluted)

$-2.26

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$421,000

Balance Sheet

Total Assets

$46M

Total Liabilities

$24M

Stockholders' Equity

$21M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$7M	-$6M	-27.2%
Net Income	-$8M	-$3M	-120.1%